scispace - formally typeset
Open AccessJournal ArticleDOI

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Mev Dominguez-Valentin, +94 more
- 01 Jan 2020 - 
- Vol. 22, Iss: 1, pp 15-25
Reads0
Chats0
TLDR
Management guidelines for Lynch syndrome may require revision in light of these different gene and gender-specific risks and the good prognosis for the most commonly associated cancers.
About
This article is published in Genetics in Medicine.The article was published on 2020-01-01 and is currently open access. It has received 334 citations till now. The article focuses on the topics: Lynch syndrome & Cancer.

read more

Citations
More filters
Journal ArticleDOI

Endometrial cancer

TL;DR: In this paper , the authors proposed minimally invasive surgical staging and sentinel-lymph-node biopsy for endometrial cancer, which provides a low morbidity alternative to historical surgical management without compromising oncological outcomes.
Journal ArticleDOI

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

Veda N. Giri, +91 more
TL;DR: This multidisciplinary, consensus-driven PCA genetic implementation framework provides novel guidance to clinicians and patients tailored to the precision era and includes optimal pretest informed consent, post-test discussion, cascade testing, and technology-based approaches.
Journal ArticleDOI

Molecular pathology of Lynch syndrome.

TL;DR: It is shown that the processes of autoimmunisation and immunoediting fundamentally constrain the development of tumours in LS and explain the efficacy of immune checkpoint blockade therapy in MMR‐deficient tumours.
References
More filters
Journal ArticleDOI

Cancer risk in mutation carriers of DNA-mismatch-repair genes.

TL;DR: The tumour spectrum associated with germline mutations of DNA‐mismatch‐repair genes involves 8 or more organ sites, suggesting a need to develop methods to screen for extra‐colonic cancer also.
Journal Article

Cancer risks associated with germline mutations in MLH1, MSH2 and MSH6 genes in Lynch syndrome: results from the large nationwide French ERISCAM study

TL;DR: In this article, the age-specific cumulative risks of developing various tumors using a large series of families with mutations of the MLH1, MSH2, and MSH6 genes were estimated using the genotype restricted likelihood (GRL) method accounting for ascertainment bias.
Journal ArticleDOI

The risk of extra‐colonic, extra‐endometrial cancer in the Lynch syndrome

TL;DR: Urologic tract cancer and ovarian cancer occur frequently enough in some LS subgroups to justify trials to evaluate promising prevention interventions, and other cancer types studied occur too infrequently to justify strenuous cancer control interventions.
Related Papers (5)